Seven Mile Advisory’s Medtronic MDT Stock Holding History

Seven Mile Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Sell	2,426 -1,223	-34%	-$117K	0.15%	159
2025 Q4	$351K	Sell	3,649 -1,108	-23%	-$108K	0.06%	147
2025 Q3	$453K	Buy	4,757 +2,190	+85%	+$201K	0.07%	142
2025 Q2	$224K	Sell	2,567 -169	-6%	-$14.3K	0.13%	154
2025 Q1	$246K	Buy	2,736 +145	+6%	+$13K	0.16%	136
2024 Q4	$207K	Buy	2,591 +333	+15%	+$28.8K	0.13%	152
2024 Q3	$203K	Buy	+2,258	New	+$190K	0.13%	156
2024 Q2	–	Sell	-2,493	Closed	-$217K	–	166
2024 Q1	$217K	Buy	+2,493	New	+$213K	0.16%	136

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seven Mile Advisory's MDT Position: Q1 2026 in Review

Seven Mile Advisory reduced its Medtronic (MDT) stake by 34% in Q1 2026, selling an estimated $117K and leaving 2,426 shares worth $210K. The position accounts for 0.15% of the portfolio, ranked #159.

Seven Mile Advisory first reported a position in MDT in Q1 2024 and has held it in 8 quarters since. The position peaked at $453K in Q3 2025. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Seven Mile Advisory held 2,426 shares of Medtronic worth $210K as of Q1 2026.
Seven Mile Advisory sold 1,223 Medtronic shares in Q1 2026, an estimated $117K.
Medtronic made up 0.15% of Seven Mile Advisory's portfolio in Q1 2026, its #159 holding.
Seven Mile Advisory first reported a position in Medtronic in Q1 2024 and has held it in 8 quarters since.
Seven Mile Advisory's Medtronic position peaked at $453K in Q3 2025.
2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.